This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
POTCAST: El Resumen Visual
¿Elevar el K⁺ al rango alto-normal puede reducir las descargas del DAI y las hospitalizaciones? POTCAST desafía nuestro miedo al potasio.
Revisa el resumen visual por Jeyakumar Meyyappan y únete a la conversación en #NephJC
POTCAST: The Visual Abstract
Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations? POTCAST challenges our fear of potassium.
Check out the VA by Jeyakumar Meyyappan and join the #NephJC conversation
The ADAPT Trial Visual Abstract
In patients with hyperkalemia on maintenance hemodialysis, whether a combination of higher dialysate potassium with SZC can reduce the rates of AF and other clinically significant arrhythmias? Check out the VA by Madiha Aziz
